Growth Metrics

Orthopediatrics (KIDS) Cost of Revenue (2016 - 2026)

Orthopediatrics has reported Cost of Revenue over the past 11 years, most recently at $18.5 million for Q1 2026.

  • For Q1 2026, Cost of Revenue rose 30.54% year-over-year to $18.5 million; the TTM value through Mar 2026 reached $81.8 million, up 36.99%, while the annual FY2025 figure was $72.7 million, 13.11% up from the prior year.
  • Cost of Revenue for Q1 2026 was $18.5 million at Orthopediatrics, down from $25.5 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $25.5 million in Q4 2025 and troughed at -$2.5 million in Q4 2023.
  • A 5-year average of $13.4 million and a median of $13.9 million in 2023 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: tumbled 126.05% in 2023 and later surged 759.49% in 2024.
  • Year by year, Cost of Revenue stood at $9.8 million in 2022, then tumbled by 126.05% to -$2.5 million in 2023, then surged by 759.49% to $16.8 million in 2024, then soared by 52.16% to $25.5 million in 2025, then dropped by 27.68% to $18.5 million in 2026.
  • Business Quant data shows Cost of Revenue for KIDS at $18.5 million in Q1 2026, $25.5 million in Q4 2025, and $18.7 million in Q3 2025.